Hereditary prostate cancer: genes related, target therapy and prevention
MT Vietri, G D'elia, G Caliendo, M Resse… - International journal of …, 2021 - mdpi.com
Prostate cancer (PCa) is globally the second most diagnosed cancer type and the most
common cause of cancer-related deaths in men. Family history of PCa, hereditary breast …
common cause of cancer-related deaths in men. Family history of PCa, hereditary breast …
Risk-reducing bilateral salpingo-oophorectomy for ovarian cancer: a review and clinical guide for hereditary predisposition genes
YL Liu, K Breen, A Catchings, M Ranganathan… - JCO oncology …, 2022 - ascopubs.org
Pathogenic germline variants underlie up to 20% of ovarian cancer (OC) and are associated
with varying degrees of risk for OC. For mutations in high-penetrance genes such as …
with varying degrees of risk for OC. For mutations in high-penetrance genes such as …
[HTML][HTML] Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome
HL Harper, JK McKenney, B Heald, A Stephenson… - Modern Pathology, 2017 - Elsevier
Increased risk for upper tract urothelial carcinoma is described in patients with Lynch
syndrome, caused by germline mutations in mismatch repair genes. We aimed to identify the …
syndrome, caused by germline mutations in mismatch repair genes. We aimed to identify the …
Risk factors for endometrial cancer or hyperplasia in adolescents and women 25 years old or younger
MW Rosen, J Tasset, EK Kobernik, YR Smith… - Journal of pediatric and …, 2019 - Elsevier
Abstract Study Objective To evaluate characteristics of young women with endometrial
hyperplasia or cancer. Design Retrospective chart review. Setting Tertiary care referral …
hyperplasia or cancer. Design Retrospective chart review. Setting Tertiary care referral …
An update on the CNS manifestations of brain tumor polyposis syndromes
B Kim, U Tabori, C Hawkins - Acta neuropathologica, 2020 - Springer
Cancer predisposition syndromes are associated with an increased risk of developing
primary malignancies. Here we discuss those which are associated with an increased risk of …
primary malignancies. Here we discuss those which are associated with an increased risk of …
Mismatch repair deficiency identifies patients with high‐intermediate–risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic …
FJ Backes, J Haag, CM Cosgrove, A Suarez… - Cancer, 2019 - Wiley Online Library
Background The objective of this study was to assess the correlation between mismatch
repair (MMR) status, disease recurrence patterns, and recurrence‐free survival (RFS) in …
repair (MMR) status, disease recurrence patterns, and recurrence‐free survival (RFS) in …
Implementing precision medicine: the ethical challenges
DM Korngiebel, KE Thummel, W Burke - Trends in pharmacological …, 2017 - cell.com
Precision medicine aims to individualize care by understanding differences in genetics,
lifestyle, and environment. Pharmacogenomics and cancer genetics represent two …
lifestyle, and environment. Pharmacogenomics and cancer genetics represent two …
Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China
X Chao, L Li, M Wu, S Ma, X Tan, S Zhong, Y Bi… - Cancer …, 2019 - Springer
Abstract Background The prevalence of Lynch syndrome and screening strategies for this
disorder in Chinese patients with endometrial cancer have seldom been investigated. Such …
disorder in Chinese patients with endometrial cancer have seldom been investigated. Such …
[HTML][HTML] Isolated loss of PMS2 immunohistochemical expression is frequently caused by heterogenous MLH1 promoter hypermethylation in Lynch syndrome …
A Kato, N Sato, T Sugawara, K Takahashi… - The American journal …, 2016 - journals.lww.com
Lynch syndrome (LS) is an autosomal-dominant inherited disorder mainly caused by a
germline mutation in the DNA mismatch repair (MMR) genes (MLH1, MSH2, MSH6, and …
germline mutation in the DNA mismatch repair (MMR) genes (MLH1, MSH2, MSH6, and …
Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer
MT Vietri, G D'Elia, G Caliendo, A Casamassimi… - Medical Oncology, 2021 - Springer
Endometrial cancer (EC) is the fifth most common cancer in women from developed
countries, accounting for 4.8% of new cases and 2.1% of deaths. The genetic basis for the …
countries, accounting for 4.8% of new cases and 2.1% of deaths. The genetic basis for the …